Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.

MLA

Labuschagne, Izelle, et al. “Emotional Face Recognition Deficits and Medication Effects in Pre-Manifest through Stage-II Huntington’s Disease.” Psychiatry Research, vol. 207, no. 1–2, May 2013, pp. 118–26. EBSCOhost, https://doi.org/10.1016/j.psychres.2012.09.022.

APA

Labuschagne, I., Jones, R., Callaghan, J., Whitehead, D., Dumas, E. M., Say, M. J., Hart, E. P., Justo, D., Coleman, A., Dar Santos, R. C., Frost, C., Craufurd, D., Tabrizi, S. J., & Stout, J. C. (2013). Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington’s disease. Psychiatry Research, 207(1–2), 118–126. https://doi.org/10.1016/j.psychres.2012.09.022

Chicago

Labuschagne, Izelle, Rebecca Jones, Jenny Callaghan, Daisy Whitehead, Eve M Dumas, Miranda J Say, Ellen P Hart, et al. 2013. “Emotional Face Recognition Deficits and Medication Effects in Pre-Manifest through Stage-II Huntington’s Disease.” Psychiatry Research 207 (1–2): 118–26. doi:10.1016/j.psychres.2012.09.022.